Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Duediligence33on Nov 13, 2018 5:01pm
177 Views
Post# 28968214

Fundamentals & Share Price & Sentiment & TA & News

Fundamentals & Share Price & Sentiment & TA & NewsThese 5 factors don't always line up accurately to reflect actual company business plans success and failures.

For example in mid August the sp rose from $ 10 to $ 20 - a 20 % gain in one day in sympathy to the Canopy/Constellation deal YET there was an unkown 1 million dollar crop loss at APH. The sentimemt was positive but FALSE.

Also by Sep 14 the sp rose from $ 12 to $ 22 just based on the expectation of a Diagio deal or an Altria halt. This was also a case of -  The sentimemt was positive but FALSE.

Now Oct 17 initial rec sales were a disaster with supply shortages & postal strikes but demand is high and future outlok good but the market "sold the news" and a downturn has occured to most  LP's and more sharply for APH.

This a case of a reverse of The sentimemt is negative but FALSE.

The company financials of Oct 12 were acceptable and superior to others just now reporting.

The phase IV and V are both complete witgh HC approval and on target for the expansion with Double diamond for 20,000 kg per month. Even with $ 1.00 profit that is 20 million per month and 240 million annual or $ 1.00 earning per share or $ 30 with NO DEAL.

The bear volume now is puny compared to the bull volume in September.
Fear instilled by shorters bodes well for capitulation coming.

Margin holders will cave in and  bargain prices will be available to smart professional traders who will join the shorters when they cover at extremley low prices and the cycle will return bullish to match the upcoming rising MJ sector as the fundamentals improve for APH with actual metrics and " the industry shake out" that Jacob referred to.

Try not to let fear make you sell at these low prices and if cash is available wait for capitulation and buy more to maximize the gains that will come by spring and summer with positively great quarterly numbers in 2019 - better than most other LP's that are priced with much higher market caps.








Bullboard Posts